Zotepine
ADVERTISEMENT
- Molecular formula
- C18H18ClNOS
- CAS Number
- 26615-21-4
- IUPAC Name
- 2-[(1-chloro-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)oxy]-N,N-dimethyl-ethanamine
- Molecular Weight
- 332.87g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2325g/cm3
- Synonyms
- AKOS005065499
Identification
Interesting facts
Interesting Facts about 2-[(1-chloro-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)oxy]-N,N-dimethyl-ethanamine
This intriguing compound belongs to a class of chemicals that has garnered attention in the field of medicinal chemistry. Here are some fascinating insights:
- Pharmaceutical Potential: Compounds like 2-[(1-chloro-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)oxy]-N,N-dimethyl-ethanamine are often investigated for their potential therapeutic applications, particularly in the realm of mental health and neuropharmacology.
- Structural Complexity: With a unique blend of aromatic systems, nitrogen functionality, and the presence of sulfur, this compound illustrates the complexity that modern synthetic chemistry can achieve. The incorporation of a chloro group further diversifies its reactivity and properties.
- Interaction Mechanism: Understanding how this compound interacts at a molecular level can provide insights into its mechanism of action, especially if it targets neurotransmitter systems.
- Research Background: This compound is part of ongoing research aimed at developing new therapeutic agents that can offer improved efficacy and reduced side effects compared to existing medications.
- Structure-Activity Relationship (SAR): The intricate structural features of this compound serve as a basis for SAR studies, which help chemists design more effective drugs by tweaking specific parts of the molecule.
In summary, the chemical and pharmacological landscape surrounding 2-[(1-chloro-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)oxy]-N,N-dimethyl-ethanamine is rich with potential explorations. As research progresses, we may uncover novel applications that highlight the significance of this compound in the development of therapeutic agents.